We are live on ! Find out more
EAM

Exome Asset Management Portfolio holdings

AUM $193M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+208.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
-$20.6M
Cap. Flow
+$957K
Cap. Flow %
0.85%
Top 10 Hldgs %
39.2%
Holding
84
New
25
Increased
14
Reduced
14
Closed
25

Top Buys

Rank Stock Value
1
COGT icon
Cogent Biosciences
COGT
+$4.87M
2
GERN icon
Geron
GERN
+$4.03M
3
VRDN icon
Viridian Therapeutics
VRDN
+$3.7M
4
DYN icon
Dyne Therapeutics
DYN
+$3.7M
5
RGNX icon
Regenxbio
RGNX
+$3.01M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$4.58M
2
RLAY icon
Relay Therapeutics
RLAY
+$4.46M
3
APLS
Apellis Pharmaceuticals
APLS
+$3.81M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
5
BSX icon
Boston Scientific
BSX
+$3.62M

Sector Composition

Rank Sector Weight
1 Healthcare 97.89%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCKT icon
76
Rocket Pharmaceuticals
RCKT
$346M
– –
-159,552
Closed -$2.01M
RLAY icon
77
Relay Therapeutics
RLAY
$4.08B
– –
-1,083,487
Closed -$4.46M
SLRN
78
DELISTED
ACELYRIN
SLRN
– –
-234,435
Closed -$736K
SMMT icon
79
Summit Therapeutics
SMMT
$10.5B
– –
-130,412
Closed -$2.33M
STOK icon
80
Stoke Therapeutics
STOK
$1.83B
– –
-113,096
Closed -$1.25M
TARS icon
81
Tarsus Pharmaceuticals
TARS
$2.68B
– –
-28,178
Closed -$1.56M
VERU icon
82
Veru
VERU
$36.4M
– –
-111,760
Closed -$693K
TECX
83
Tectonic Therapeutic
TECX
$530M
– –
-26,081
Closed -$1.2M
1 2 3
4

Similar funds

WWC
Waypoint Wealth Counsel Atlanta, Georgia $193M AUM 30.17% 1-Year Est. Return
JHA
Jackson Hill Advisors Houston, Texas $193M AUM 4.94% 1-Year Est. Return
TDWM
Topel & Distasi Wealth Management Berkeley, California $193M AUM 12.07% 1-Year Est. Return
DF
Downshift Financial Boulder, Colorado $193M AUM
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
PA
Promethium Advisors Bethesda, Maryland $193M AUM 23.69% 1-Year Est. Return
SCPM
Sea Cliff Partners Management San Francisco, California $194M AUM 8.22% 1-Year Est. Return
CA
Carson Advisory Athens, Georgia $193M AUM 14.52% 1-Year Est. Return

Exome Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Exome Asset Management held 84 positions worth $112M, down 15% from $133M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Exome Asset Management's Q1 2025 filing shows 25 new, 14 increased, 14 reduced and 25 closed positions. Its largest new stake was Cogent Biosciences: 621,678 shares worth $3.72M. The largest sale was Humana, an estimated $4.58M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier, followed by Financials.

  • Exome Asset Management's largest Q1 2025 buy was Cogent Biosciences: 621,678 shares worth $3.72M.
  • Exome Asset Management added most to Geron in Q1 2025, an estimated $4.03M increase.
  • Exome Asset Management's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $2.97M.
  • Exome Asset Management fully exited Humana in Q1 2025, selling an estimated $4.58M.
  • Exome Asset Management's ten largest holdings make up 39% of its $112M portfolio in Q1 2025.
  • Exome Asset Management opened 25 new positions and closed 25 in Q1 2025.
  • Exome Asset Management's portfolio value fell 15% quarter-over-quarter to $112M.

Based on Exome Asset Management's 13F filing for Q1 2025, filed 15 May 2025.